Form 4: LeMaitre Vascular Executive Trent G. Kamke Reports Stock Transactions

Senior VP of Operations at LeMaitre Vascular, Trent G. Kamke, reports the acquisition of shares through dividend equivalent rights and the disposal of shares to cover tax obligations.

Summary

• Trent G. Kamke, Senior VP of Operations at LeMaitre Vascular, reported transactions involving the company's common stock.
• On December 9, 2024, Kamke acquired 2 shares of common stock through the release of dividend equivalent rights.
• Also on December 9, 2024, 77 shares were disposed of to cover tax obligations related to the vesting of restricted stock units.
• The price of the disposed shares was $101.12 per share.
• Following these transactions, Kamke beneficially owns 5,369 shares of LeMaitre Vascular common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the transactions are routine and expected. The sale of shares is for tax purposes and not indicative of a negative outlook.

Positives

• The acquisition of shares through dividend equivalent rights indicates a positive return on previous stock awards.

Negatives

• The sale of shares to cover tax obligations resulted in a reduction of Kamke's holdings.

Risks

• The sale of shares by an executive could be perceived negatively by some investors, although it is a common practice for tax purposes.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the trading activities of insiders.

Comparison to Industry Standards

• The reporting of stock transactions by executives is a standard practice for publicly traded companies, as mandated by the SEC.
• Similar filings are made by executives at comparable medical device companies such as Boston Scientific (BSX) and Medtronic (MDT) when they engage in stock transactions.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are routine and do not indicate a change in the company's fundamentals.

Key Dates

Keywords

LeMaitre Vascular, insider trading, stock transaction, Form 4, dividend equivalent rights, restricted stock units, executive compensation, LMAT